GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cline Scientific AB (OSTO:CLINE B) » Definitions » Equity-to-Asset

Cline Scientific AB (OSTO:CLINE B) Equity-to-Asset : 0.89 (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Cline Scientific AB Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Cline Scientific AB's Total Stockholders Equity for the quarter that ended in Dec. 2023 was kr20.10 Mil. Cline Scientific AB's Total Assets for the quarter that ended in Dec. 2023 was kr22.72 Mil.

The historical rank and industry rank for Cline Scientific AB's Equity-to-Asset or its related term are showing as below:

OSTO:CLINE B' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.26   Med: 0.88   Max: 0.93
Current: 0.89

During the past 9 years, the highest Equity to Asset Ratio of Cline Scientific AB was 0.93. The lowest was 0.26. And the median was 0.88.

OSTO:CLINE B's Equity-to-Asset is ranked better than
83.35% of 1556 companies
in the Biotechnology industry
Industry Median: 0.67 vs OSTO:CLINE B: 0.89

Cline Scientific AB Equity-to-Asset Historical Data

The historical data trend for Cline Scientific AB's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cline Scientific AB Equity-to-Asset Chart

Cline Scientific AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only 0.27 0.91 0.91 0.93 0.89

Cline Scientific AB Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.91 0.90 0.93 0.94 0.89

Competitive Comparison of Cline Scientific AB's Equity-to-Asset

For the Biotechnology subindustry, Cline Scientific AB's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cline Scientific AB's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cline Scientific AB's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Cline Scientific AB's Equity-to-Asset falls into.



Cline Scientific AB Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Cline Scientific AB's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=20.104/22.721
=

Cline Scientific AB's Equity to Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

Equity to Asset (Q: Dec. 2023 )=Total Stockholders Equity/Total Assets
=20.104/22.721
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cline Scientific AB  (OSTO:CLINE B) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Cline Scientific AB Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Cline Scientific AB's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Cline Scientific AB (OSTO:CLINE B) Business Description

Traded in Other Exchanges
N/A
Address
Vastra Gotalands Lan, 2C Argongatan, Molndal, SWE, 43153
Cline Scientific AB develops and markets products for biomedical research based on proprietary nanotechnology. Its products include unique surfaces for use in stem cell & cancer research and customized nanoparticles for use in biomedical applications.

Cline Scientific AB (OSTO:CLINE B) Headlines

No Headlines